XOMA Royalty Corp
DelistedCIK 791908fmd_0FZ8W0JT5PBDYT2D863G70Y3WXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2026, 66 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 6 | 53 | 5 | 18 | 29 | 38 | 6 | 5 | 28 | 52 |
| Rental revenue | – | – | – | – | – | – | – | – | – | – |
| Cost of revenue | – | – | – | – | – | – | – | – | – | – |
| Gross profit | – | – | – | – | – | – | – | – | – | – |
| Research and development | 44 | 8 | 2 | 1 | 0 | 0 | 0 | 0 | 3 | 2 |
| Selling, general and administrative | 18 | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 67 | 36 | 22 | 22 | 17 | 21 | 23 | 47 | 68 | 41 |
| Operating income | (62) | 17 | (17) | (4) | 12 | 18 | (17) | (42) | (40) | 11 |
| Interest expense | 4 | 1 | 1 | 2 | 2 | 0 | – | 1 | 14 | 13 |
| Other non-operating income (expense) | – | 1 | 4 | 4 | 1 | (1) | 0 | 2 | 7 | 12 |
| Income before taxes | (54) | 16 | (13) | (2) | 12 | 16 | (17) | (41) | (19) | 32 |
| Income tax expense | 0 | 2 | (0) | 0 | (2) | 0 | (0) | 0 | (6) | 0 |
| Net income from continuing operations | (54) | 15 | (13) | (2) | 13 | 16 | (17) | (41) | (14) | 32 |
| Net income | (54) | 15 | (13) | (2) | 13 | 16 | (17) | (41) | (14) | 32 |
| Net income to common shareholders | (54) | 6 | (13) | (2) | 9 | 8 | (23) | (46) | (19) | 19 |